Clincosm LogoSign in Get a demo

indolent systemic mastocytosis

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

Recruiting
  • Indolent Systemic Mastocytosis
  • Monoclonal Mast Cell Activation Syndrome
  • Palo Alto, California
  • +33 more
Jul 27, 2022

Indolent Systemic Mastocytosis Trial in Worldwide (Avapritinib, Placebo)

Active, not recruiting
  • Indolent Systemic Mastocytosis
  • Birmingham, Alabama
  • +48 more
Jan 19, 2022

Indolent Systemic Mastocytosis Trial in France, Germany, United States (Masitinib, Placebo, Best Supportive Care)

Recruiting
  • Indolent Systemic Mastocytosis
  • Rochester, Minnesota
  • +6 more
Nov 29, 2021

Indolent Systemic Mastocytosis Trial in France, United States (Masitinib, Placebo, Best Supportive Care)

Completed
  • Indolent Systemic Mastocytosis
  • Sacramento, California
  • +23 more
Nov 29, 2019

Adaptation of Questionnaire "Regarding Patient's Quality of Life

Completed
  • Cutaneous Mastocytosis
  • Indolent Systemic Mastocytosis
  • A structured interview with every patient
  • Toulouse, France
    University Hospital Toulouse
Jul 15, 2019

Indolent Systemic Mastocytosis Trial in Berlin (AK002)

Completed
  • Indolent Systemic Mastocytosis
  • Berlin, Germany
    Charité - Universitätsmedizin Berlin
Mar 12, 2019

Mastocytosis, Systemic Mastocytosis, Indolent Systemic Mastocytosis Trial in Worldwide (PA101, Placebo)

Completed
  • Mastocytosis
  • +2 more
  • Paris, France
  • +7 more
Sep 27, 2016

Indolent Systemic Mastocytosis Trial in Groningen (Midostaurin,)

Unknown status
  • Indolent Systemic Mastocytosis
  • Groningen, Netherlands
    University Medical Center Groningen
Jan 15, 2015